Hebei Kexing Pharmaceutical Co., Ltd.
Model No.: 25% 30%
Varieties: Infectious Disease Prevention Medicine
Component: Chemical Synthetic Drugs
Type: The First Class
Pharmacodynamic Influential Factors: Repeated Medication
Storage Method: Moisture Proof
Productivity: 20000 bottles per day
Place of Origin: Hebei, China (Mainland)
Supply Ability: 20000 bottles per day
Certificate: GMP ISO
HS Code: 3004909099
Tilmicosin Injection is a broad-spectrum semi-synthetic bactericidal macrolide antibiotic synthesized from Tylosin. 100ml Tilmicosin Injection has an antibacterial spectrum that is predominantly effective against Mycoplasma, Pasteurella and Haemophilus spp. and various Grampositive organisms such as Corynebacterium spp. Tilmicosin Injection is believed to affect bacterial protein synthesis through binding to 50S ribosomal subunits. Crossresistance between tilmicosin and other macrolide antibiotics has been observed. Tilmicosin Injection is excreted mainly via the bile into the faeces, with a small proportion being excreted via the urine.
Animals Tilmicosin Injection indicated for the control and treatment of respiratory infections associated
with tilmicosin-susceptible microorganisms such as Mycoplasma spp. Pasteurella multocida, Actinobacillus
pleuropneumoniae, Actinomyces pyogenes and Mannheimia haemolytica in calves, chickens, turkeys and
For oral administration.
Calves : Twice daily, 1 ml per 20 kg body weight via (artificial) milk for 3 - 5 days.
Poultry : 300 ml per 1000 litres of drinking water (75 ppm) for 3 days.
Swine : 800 ml per 1000 litres of drinking water (200 ppm) for 5 days.
- For meat:
Calves : 42 days.
Broilers : 12 days.
Turkeys : 19 days.
Swine : 14 days.
Keep out of reach of children.
Copyright © 2019 Hebei Kexing Pharmaceutical Co., Ltd. All rights reserved.